Cowealth Medical Holding Co Ltd (4745) fair value: what the stock is really worth
As of Oct 8, 2026: fair value of Cowealth Medical Holding Co Ltd TWD 16.01, price TWD 12.20, upside +31.2%, quality 38 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others.
Show more
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision making, multi-channel coaxial-time-audio-video-image digital platform for operating rooms, and cross-trait medical resource platform. In addition, it provides equipment comprising CyberKnife Stereotactic Radiosurgery System, a non-invasive treatment alternative for cancerous and non-cancerous tumors, as well as other medical conditions requiring radiation therapy; LipiView Ocular Surface Interferometer and LipiView Thermal Pulsation System, a system designed to diagnose and address meibomian gland dysfunction; and MRIdian-Linac, an MRI-guided radiation therapy system. Further, the company is involved in general investing; import and export medical equipment, reagents, and spare parts; nutrition, health, and social and economic consulting business; software development, IT equipment maintenance, and IT system maintenance service; and hospital and business management. Cowealth Medical Holding Co., Ltd. was founded in 1997 and is based in George Town, Cayman Islands.
Stock analysis
Cowealth Medical Holding Co Ltd (4745) currently trades at 12.20 TWD, while our model-based Fair Value estimate is 16.01 TWD, implying the stock looks roughly 23.8% undervalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 29.04 TWD per share, and 6 of the 8 models we run sit above the 12.20 TWD price.
Bear case: the Dividend Discount group reads lowest at 4.48 TWD, and 2 of the 8 models stay below the price. Evidence for this calculation is low.
Scenario range: 15.86 TWD (bear) to 16.13 TWD (bull), the price of 12.20 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Cowealth Medical Holding Co Ltd reported revenue of 3.0B TWD in FY2025 versus 5.1B TWD in FY2021, a compound −12.9%/yr. Reported net income was −247M TWD in FY2025.
Key figures
Market cap 945M TWD (≈ $29.6M) · P/S ratio 0.28 · EPS (TTM) −3.24 TWD · Dividend yield 3.8% · Net margin −8.3% · Return on equity −7.4% · Return on assets (EBIT) 3.3% · Operating margin −5.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (medium confidence).
What moves the price
The share trades about 55% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at 31%, 4745 screens cheaper than that median.
Fair Value models
Bear 15.86 TWDFair Value 16.01 TWDBull 16.13 TWD
Price 12.20 TWD · Upside +31.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−29.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−19.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.9%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.3%
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
9.1% (2020) → −6.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Cowealth Medical Holding Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 329 stocks
Beats the industry median on 4/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside+31.2% · Top 25%
Profitability
Return on assets−2.7% · Below median
Net margin (TTM)−8.6% · Bottom 25%
Operating margin (TTM)−5.3% · Bottom 25%
Growth and dividend
Revenue growth4.3% · Below median
Dividend yield (TTM)3.8% · Top 25%
Balance sheet
Debt / equity0.00× · Below median
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cowealth Medical Holding Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/4745
Frequently asked questions
Is Cowealth Medical Holding Co Ltd (4745) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of 16.01 TWD versus a price of 12.20 TWD, about +31% upside (undervalued).
What is the fair value of 4745?
Our model-based fair value for Cowealth Medical Holding Co Ltd is 16.01 TWD (as of Oct 4, 2026), built from audited fundamentals. The current price: 12.20 TWD.
What is the quality score of 4745?
Cowealth Medical Holding Co Ltd has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cowealth Medical Holding Co Ltd (4745)?
Our model-based price target is the fair value of 16.01 TWD (as of Oct 4, 2026) from 8 valuation models. Cautious scenario 15.86 TWD, optimistic scenario 16.13 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Cowealth Medical Holding Co Ltd stock forecast for 2026?
Our models put fair value at 16.01 TWD, about +31% upside versus a price of 12.20 TWD (undervalued). Cautious scenario 15.86 TWD, optimistic scenario 16.13 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Cowealth Medical Holding Co Ltd (4745)?
Cowealth Medical Holding Co Ltd reported trailing-twelve-month revenue of about 2.9B TWD (latest available figure, as of Oct 4, 2026).
Does Cowealth Medical Holding Co Ltd pay a dividend?
Cowealth Medical Holding Co Ltd currently shows a dividend yield of about 3.83% relative to its recent price (as of Oct 4, 2026).
What is the intrinsic value of Cowealth Medical Holding Co Ltd (4745)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cowealth Medical Holding Co Ltd it is 16.01 TWD per share (as of Oct 4, 2026), against a price of 12.20 TWD. It is the blended result of 8 valuation models (cash flow, earnings, asset, dividend).
Is Cowealth Medical Holding Co Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, 4745 trades below its calculated fair value: price 12.20 TWD, fair value 16.01 TWD, a gap of about +31% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4745?
No. The price is what the market pays today (12.20 TWD); the fair value is what the company's own numbers justify (16.01 TWD). For Cowealth Medical Holding Co Ltd the two are 3.81 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Cowealth Medical Holding Co Ltd worth?
The market values Cowealth Medical Holding Co Ltd at about 945M TWD (market capitalisation, as of Oct 4, 2026). Per share that is 12.20 TWD; our models calculate a fair value of 16.01 TWD per share.
What do the bullish and bearish scenarios say about 4745?
Our models span a range for Cowealth Medical Holding Co Ltd: cautious scenario 15.86 TWD, base 16.01 TWD, optimistic 16.13 TWD per share (as of Oct 4, 2026, price 12.20 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cowealth Medical Holding Co Ltd (4745)?
Balance-sheet figures for Cowealth Medical Holding Co Ltd (as of Oct 4, 2026): return on equity −7.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is 4745 from its 52-week high?
Cowealth Medical Holding Co Ltd trades at 12.20 TWD, about 55% below its 52-week high of 26.85 TWD and 17% above the low of 10.40 TWD (as of Oct 8, 2026). Distance from the high says nothing about value: that is what the fair value of 16.01 TWD is for.
Which stocks are comparable to Cowealth Medical Holding Co Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cowealth Medical Holding Co Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price 12.20 TWD, calculated fair value 16.01 TWD (+31%), Quality Score 38/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4745 calculated?
We run Cowealth Medical Holding Co Ltd through 8 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 16.01 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Cowealth Medical Holding Co Ltd currently trades 24 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cowealth Medical Holding Co Ltd (4745)?
The closing price on Oct 8, 2026 was 12.20 TWD. Our model-based fair value is 16.01 TWD, about +31% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cowealth Medical Holding Co Ltd right now?
The large discount to fair value meets weak quality (38/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (15.86 TWD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (15.86 TWD to 16.13 TWD), unusually little disagreement for a valuation.
Key figures of Cowealth Medical Holding Co Ltd
How large is the market capitalisation of Cowealth Medical Holding Co Ltd (4745)?
The market capitalisation of Cowealth Medical Holding Co Ltd is 945M TWD (≈ $29.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cowealth Medical Holding Co Ltd (4745)?
The price-to-sales ratio of Cowealth Medical Holding Co Ltd is 0.28 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cowealth Medical Holding Co Ltd (4745)?
Earnings per share at Cowealth Medical Holding Co Ltd are −3.24 TWD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cowealth Medical Holding Co Ltd (4745)?
The dividend yield of Cowealth Medical Holding Co Ltd is 3.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cowealth Medical Holding Co Ltd (4745)?
The net margin of Cowealth Medical Holding Co Ltd is −8.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cowealth Medical Holding Co Ltd (4745)?
The return on equity (ROE) of Cowealth Medical Holding Co Ltd is −7.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cowealth Medical Holding Co Ltd (4745)?
On an EBIT basis the return on assets of Cowealth Medical Holding Co Ltd is 3.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cowealth Medical Holding Co Ltd (4745)?
The operating margin of Cowealth Medical Holding Co Ltd is −5.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cowealth Medical Holding Co Ltd (4745)?
Revenue at Cowealth Medical Holding Co Ltd is growing +4.3% versus a year earlier (3y avg −19.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cowealth Medical Holding Co Ltd (4745)?
Earnings per share at Cowealth Medical Holding Co Ltd are growing −80.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Cowealth Medical Holding Co Ltd (4745) generate?
The free cash flow of Cowealth Medical Holding Co Ltd is 836K TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Cowealth Medical Holding Co Ltd (4745) carry?
The net debt of Cowealth Medical Holding Co Ltd is 60.9M TWD (fiscal year 2025, ≈ 72.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cowealth Medical Holding Co Ltd in the live analysis
One click puts Cowealth Medical Holding Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
